Dynacure

YTD

ALL

Why Robinhood?

You can watch Dynacure and buy or sell other stocks, ETFs, and their options commission-free!

About DYCU

Dynacure is a clinical-stage drug development company focused on improving the lives of patients with rare and orphan diseases.The Dynacure team leverages its proven track record in rare disease drug development to build a pipeline of novel drugs. Dynacure is developing DYN101, an investigational antisense medicine designed to modulate the expression of dynamin 2 for the treatment of Centronuclear Myopathies, with Ionis Pharmaceuticals.

CEO

Stephane van Rooijen, MD, MBA

CEOStephane van Rooijen, MD, MBA

Employees

—

Employees—

Headquarters

Illikirch-Graffenstaden, Grand Est

HeadquartersIllikirch-Graffenstaden, Grand Est

Founded

2016

Founded2016

Employees

—

Employees—

DYCU Key Statistics

Market cap

—

Market cap—

Price-Earnings ratio

—

Price-Earnings ratio—

Dividend yield

—

Dividend yield—

Average volume

—

Average volume—

High today

—

High today—

Low today

—

Low today—

Open price

—

Open price—

Volume

0.00

Volume0.00

52 Week high

—

52 Week high—

52 Week low

—

52 Week low—

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.